IRIS - Res&Arch Institutional Research Information System - Research & Archive

PALLOTTA, MARIA TERESA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.729
EU - Europa 2.304
AS - Asia 2.245
SA - Sud America 312
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 7.650
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.657
SG - Singapore 981
IT - Italia 700
CN - Cina 352
HK - Hong Kong 304
VN - Vietnam 289
IE - Irlanda 282
BR - Brasile 224
FR - Francia 224
RU - Federazione Russa 214
DE - Germania 199
RO - Romania 177
FI - Finlandia 93
UA - Ucraina 90
GB - Regno Unito 81
IN - India 65
SE - Svezia 64
KR - Corea 45
BE - Belgio 40
AR - Argentina 37
CZ - Repubblica Ceca 34
CA - Canada 33
MX - Messico 25
TR - Turchia 25
JP - Giappone 24
NL - Olanda 24
BD - Bangladesh 22
IQ - Iraq 19
ID - Indonesia 17
PK - Pakistan 16
PL - Polonia 16
CO - Colombia 15
ZA - Sudafrica 15
AT - Austria 14
CH - Svizzera 14
VE - Venezuela 14
EC - Ecuador 11
ES - Italia 11
PH - Filippine 10
SA - Arabia Saudita 8
UZ - Uzbekistan 8
AZ - Azerbaigian 7
CI - Costa d'Avorio 7
GR - Grecia 7
LT - Lituania 7
AE - Emirati Arabi Uniti 6
TN - Tunisia 6
IL - Israele 5
JO - Giordania 5
LB - Libano 5
ET - Etiopia 4
EU - Europa 4
MA - Marocco 4
TH - Thailandia 4
CL - Cile 3
GT - Guatemala 3
IR - Iran 3
KE - Kenya 3
KZ - Kazakistan 3
MK - Macedonia 3
OM - Oman 3
PE - Perù 3
AO - Angola 2
BH - Bahrain 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
KW - Kuwait 2
MT - Malta 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PY - Paraguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
BT - Bhutan 1
BZ - Belize 1
CG - Congo 1
CU - Cuba 1
GD - Grenada 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
ML - Mali 1
MN - Mongolia 1
MR - Mauritania 1
NI - Nicaragua 1
PA - Panama 1
PF - Polinesia Francese 1
PR - Porto Rico 1
Totale 7.640
Salva come PNG Salva come JPEG
Città #
Singapore 748
Perugia 406
Chandler 329
Hong Kong 302
Dublin 282
San Jose 223
Ashburn 190
Dong Ket 167
Bucharest 155
San Mateo 140
Boardman 122
Beijing 109
Santa Clara 106
Munich 90
Moscow 81
Redmond 77
Los Angeles 70
Wilmington 66
Medford 58
Princeton 57
Lauterbourg 56
Altamura 55
Ann Arbor 54
Seoul 44
Lawrence 42
Brussels 40
Andover 39
Jacksonville 35
Ho Chi Minh City 34
New York 33
Council Bluffs 31
The Dalles 31
Des Moines 27
Pisa 26
Dallas 25
Helsinki 25
Turku 23
Chennai 21
Hanoi 21
Falls Church 20
Tokyo 20
Chicago 18
Dearborn 18
Olomouc 18
Rome 18
Orem 17
Redwood City 17
Saint Petersburg 16
Brno 15
Denver 15
West Jordan 14
Columbus 13
Frankfurt am Main 13
Fremont 13
Johannesburg 13
Montreal 13
Nuremberg 13
Phoenix 13
Piscataway 13
São Paulo 13
Norwalk 12
San Paolo di Civitate 12
Warsaw 12
Atlanta 11
Chiajna 11
Enfield 11
Guangzhou 11
Izmir 11
Poplar 11
Stockholm 11
Haiphong 10
Lappeenranta 10
Manchester 10
Milan 10
Măgurele 10
Terni 10
Amsterdam 9
Brooklyn 9
Hefei 9
Houston 9
London 9
Woodbridge 9
Bologna 8
Boston 8
Da Nang 8
Mumbai 8
Nanjing 8
Querétaro 8
San Francisco 8
Toronto 8
Abidjan 7
Buenos Aires 7
Rio de Janeiro 7
Riyadh 7
Vicenza 7
Baku 6
Caracas 6
City of London 6
Ottawa 6
San Diego 6
Totale 5.119
Salva come PNG Salva come JPEG
Nome #
Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1 226
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 211
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 202
Amino-acid sensing and degrading pathways in immune regulation 194
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 191
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 190
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 181
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 181
Amino acid metabolism as drug target in autoimmune diseases 178
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry 176
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 173
87P - Towards the identification of the mechanism of action of antitumor 1-methyl-D-tryptophan 156
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 150
88P - Relationship between functions and intracellular localization of the immune checkpoint target indoleamine 2, 3-dioxygenase 1 150
LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism 142
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 141
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 139
The TGF-β/IDO axis in infectious tolerance. 134
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 134
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls 131
Pharmacologic Induction of Endotoxin Tolerance in Dendritic Cells by L-Kynurenine 129
The [1,2,4]Triazolo[4,3-a]pyridine as a New Player in the Field of IDO1 Catalytic Holo-Inhibitors 129
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 127
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 123
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity 123
AhR-Mediated, Non-Genomic Modulation of IDO1 Function 120
Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation 119
Different partners, opposite outcomes: A New Perspective of the Immunobiology of Indoleamine 2,3-Dioxygenase 118
Amino acid metabolism in rheumatoid arthritis: Friend or foe? 117
Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine 114
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 110
Unconventional Pathways of Protein Secretion: Mammals vs. Plants 106
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 106
Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients 106
WESTERN BLOT IDENTIFICATION OF NPM1 LEUKEMIC MUTANTS IN CYTOLOGICAL AML SAMPLES: A POWERFUL DIAGNOSTIC TECHNIQUE 103
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 102
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. 100
Extracellular Vesicles in Aging: An Emerging Hallmark? 98
Reinstalling immune regulatory tryptophan catabolism in juvenile diabetes via interleukin 6 receptor blockade 97
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 96
The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1 95
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma 94
Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells 94
CTLA-4-immunoglobulin and indoleamine 2,3 dioxygenase in dominant tolerance. 93
Human Indoleamine 2,3-dioxygenase 1 (IDO1) Expressed in Plant Cells Induces Kynurenine Production 92
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 91
Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity 91
IDO1 and TGF-β mediate protective effects of IFN-α in antigen-induced arthritis 90
Wolfram syndrome, a rare neurodegenerative disease: From pathogenesis to future treatment perspectives 88
Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme 82
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 82
Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function 81
Sensing of an HIV-1-Derived Single-Stranded RNA-Oligonucleotide Induces Arginase 1-Mediated Tolerance 81
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 81
Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8 Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3). 80
Topical application of soluble CD83 induces IDO-mediated immune modulation, increases foxp3+ T cells, and prolongs allogeneic corneal graft survival 79
FGF2 and IL-1β - explorers of unconventional secretory pathways at a glance 76
Unconventional Transport Routes of Soluble and Membrane Proteins and Their Role in Developmental Biology 75
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 74
Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 72
Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 68
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 66
Identification of a Compound Inhibiting Both the Enzymatic and Nonenzymatic Functions of Indoleamine 2,3-Dioxygenase 1 63
Moonlighting Proteins Are Important Players in Cancer Immunology 60
PROTEASOME INHIBITION IN pDCs CONFERS AN IDO-DEPENDENT IMMUNOREGULATORY PHENOTYPE 59
Vedere per credere: utilizzo della microscopia per lo studio dell’immunologia 58
Western blot identification of NPM1 leukemic mutants in cytological AML samples: A powerful diagnostic technique 57
GLP-1 receptor agonists as promising disease-modifying agents in WFS1 spectrum disorder 48
Indoleamine 2,3 dioxygnenase: as an inducer and amplifier of regulatory T cell functions. 48
IDO-TARGETING INTERVENTION IN AUTOIMMUNE DIABETES BY PROTEASOME INHIBITION 46
Gallic acid released by a layered double hydroxide-coated scaffold of hydroxyapatite and β-tricalcium phosphate inhibits the osteoclast formation In Vitro 20
Adverse pro-tumorigenic effects of IDO1 catalytic inhibitors mediated by the non-enzymatic function of IDO1 in tumor cells 16
Totale 7.923
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.634
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.634
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021230 0 0 0 0 0 0 0 0 0 23 35 172
2021/2022861 8 106 15 18 28 17 6 153 101 116 94 199
2022/20231.122 61 190 16 84 105 99 2 64 388 14 87 12
2023/2024607 27 69 21 13 8 11 158 18 42 35 65 140
2024/20251.301 21 98 57 107 124 87 104 141 212 71 171 108
2025/20262.750 166 181 168 364 389 305 474 189 297 217 0 0
Totale 7.923